ADAP
Qube Research & Technologies (QRT)’s Adaptimmune Therapeutics ADAP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-10,113
| Closed | -$1.99K | – | 2707 |
|
|
2025
Q1 | $1.99K | Buy |
+10,113
| New | +$1.99K | ﹤0.01% | 2647 |
|
|
2024
Q1 | – | Sell |
-2,087
| Closed | -$1.66K | – | 3889 |
|
|
2023
Q4 | $1.66K | Sell |
2,087
-19,474
| -90% | -$15.4K | ﹤0.01% | 3402 |
|
|
2023
Q3 | $16.8K | Sell |
21,561
-78,589
| -78% | -$61.3K | ﹤0.01% | 2761 |
|
|
2023
Q2 | $92.6K | Buy |
100,150
+52,326
| +109% | +$48.4K | ﹤0.01% | 1888 |
|
|
2023
Q1 | $52.1K | Buy |
47,824
+20,823
| +77% | +$22.7K | ﹤0.01% | 2158 |
|
|
2022
Q4 | $39.4K | Buy |
+27,001
| New | +$39.4K | ﹤0.01% | 2098 |
|
|
2022
Q3 | – | Sell |
-43,966
| Closed | -$75K | – | 2415 |
|
|
2022
Q2 | $75K | Buy |
+43,966
| New | +$75K | ﹤0.01% | 2018 |
|
|
2020
Q2 | – | Sell |
-12,167
| Closed | -$33K | – | 1683 |
|
|
2020
Q1 | $33K | Buy |
+12,167
| New | +$33K | ﹤0.01% | 1030 |
|